SCHEMBL7344377

SCHEMBL7344377

CCOC(=O)CCN(C(C)(C)C(=O)NO)S(=O)(=O)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.48
MMP1 P03956 2/20 0.39
MMP13 P45452 2/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
MMP7 P09237 1/20 0.38
MMP8 P22894 1/20 0.38
MMP12 P39900 1/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
BID P55957 1/20 0.38
BCL2A1 Q16548 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809658 0.92 MMP13 (0.50) SMN1; SMN2MMP1MMP13MMP2MMP9
SCHEMBL7344819 0.87 MMP1 (0.43) MMP1MMP13MMP2MMP9MMP7
SCHEMBL6813468 0.82 MMP1 (0.44) MMP1MMP13MMP2MMP9GAA
SCHEMBL231737 0.80 MMP1 (0.55) MMP1MMP13MMP2MMP9ALDH1A1
SCHEMBL7421019 0.73 SMN1; SMN2 (0.46) SMN1; SMN2MMP1MMP13MMP2MMP9
SCHEMBL7347709 0.72 MMP1 (0.56) SMN1; SMN2MMP1MMP13MMP2MMP9
SCHEMBL7346276 0.71 SMN1; SMN2 (0.45) SMN1; SMN2MMP1MMP13MMP2MMP9
SCHEMBL6817940 0.69 MMP1 (0.48) MMP1MMP13MMP2MMP9MMP7
SCHEMBL7346271 0.67 SMN1; SMN2 (0.52) SMN1; SMN2MMP1MMP13ALDH1A1MMP7
SCHEMBL6500736 0.67 KMT2A (0.56) SMN1; SMN2ALDH1A1GAAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0895988-B1 Arylsulfonylamino hydroxamic acid derivatives PFIZER PROD INC (US) 2002-05-22 EP claimed
US-6107337-A ANTIARTHRITIC AGENTS; ANTICARCINOGENIC AGENTS PFIZER INC. (US) 2000-08-22 US claimed
EP-0895988-A1 Arylsulfonylamino hydroxamic acid derivatives Pfizer Products Inc. (US) 1999-02-10 EP claimed
EP-0895988-B1 Arylsulfonylamino hydroxamic acid derivatives PFIZER PROD INC (US) 2002-05-22 EP disclosed
US-6107337-A ANTIARTHRITIC AGENTS; ANTICARCINOGENIC AGENTS PFIZER INC. (US) 2000-08-22 US disclosed
EP-0895988-A1 Arylsulfonylamino hydroxamic acid derivatives Pfizer Products Inc. (US) 1999-02-10 EP disclosed